Skip to Main Content

Paper Details

Artificial intelligence for drug response prediction in disease models.
Brief Bioinform
13
2022
Author NameAffiliation
Benjamin Haibe-KainsPrincess Margaret Cancer Centre, University Health Network
Benjamin Haibe-KainsDalla Lana School of Public Health
Benjamin Haibe-KainsVector Institute for Artificial Intelligence
Benjamin Haibe-KainsOntario Institute of Cancer Research
Benjamin Haibe-KainsUniversity of Toronto
Benjamin Haibe-KainsUniversity of Toronto
Benjamin Haibe-KainsPrincess Margaret Cancer Centre, University Health Network
Benjamin Haibe-KainsUniversity of Toronto
Benjamin Haibe-KainsUniversity of Toronto
Benjamin Haibe-KainsOntario Institute of Cancer Research
Benjamin Haibe-KainsVector Institute for Artificial Intelligence
Benjamin Haibe-KainsDalla Lana School of Public Health
Tero AittokallioInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Tero AittokallioInstitute for Cancer Research (ICR), Oslo University Hospital
Tero AittokallioUniversity of Oslo
  • 1 - 15

Datasets

Release 1.2